Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Tuesday, June 30

ST S Tck

22171 Skin test reactivity to Mycobacterium avium sensitin (MAS) in HIV+
persons with and without disseminated MAC and highly active
antiretroviral therapy (HAART)
Lorraine Alexander*; CR. Horsburgh, Jr.;J.L. Lennox; C.F. von Reyn, USA
22172 Manifestation of mycobacterial infection after initiating of highly active
antiretroviral therapy (HAART)
Christian Hoffmann*; H.A. Horst; 0. Degen; J. Van Lunzen; HJ. Stellbrink,
Geramy
22173 Is a response to amikacin therapy predictive of MAC infection?
Ann Sullivan; M. Hannan; B. Azadian; M. Nelson; B. Gazzard, UK
22174 Mycobacterium avium intracellulare complex infection in HIV-infected
children
Anna Maccabruni*; D. Caselli; L. Arlandi; I. Pacati; B. Castiglioni;
G. Michelone, Italy
22175 Is MAC prophylaxis necessary in HIV-positive individuals responding to
antiretroviral therapy?
Jas Gill*; G. Moyle; B.S. Gazzard; M.R. Nelson, UK
22176 A placebo-controlled trial of Rifabutin added to a regimen of
Clarithromycin and Ethambutol in the treatment of M. avium complex
(MAC) bacteremia
Fred Gordin*; P. Sullam; S. Shafran; D. Cohn; C.R. Horsburgh, USA
22177 Molecular and clinical evidence for pneumocystis carinii strains of low
pathogenicity from Africa compared to the U.S./Europe/Australia
Sten H. Vermund*;S. Lucas; M.S. Bartlett; X. Tang; M.P. Bhatta;
J. W. Smith; C.H. Lee, UK
22178 Atovaquone suspension (ATQ) for prophylaxis of pneumocystis carinii
pneumonia (PCP): Effects of baseline prophylaxis on safety and efficacy
Paul Caldwell*; Robert Murphy; C Chan; T. Yurik;J. Scott; P. Caldwell;
W. EI-Sadr, USA
22179 Withdrawal of primary prophylaxis against P. carinii and T. gondii in
adult HIV-1 infected individuals with stable CD4 cell count above
200/IgL
C. Tortajada*; E. Martinez; J.M. Mird; A. del Rio;J.M. Gatell, Spain
22180 Is it safe to stop primary PCP prophylaxis in patients treated with
antiretroviral combination regimens?
Hansjakob Furrer; M. Opravil; E. Bernasconi; D. Anwar; M. Battegay;
A. Frank; A. Telenti; M. Rickenbach; M. Egger; R. Maliverni
22181 A randomized trial of cotrimoxazole and dapsone-pyrimethamine for
primary prophylaxis of P.Carinii Pneumonia (PCP) and Toxoplasmic
Encephalitis (TE)
Rita Murri*; A. Antinori; P. Pezzotti;A. Ammassari;A. Cingolani;
A. de Luca; L. Ortana, Italy
22182 The role of aerosolized pentamidine prophylaxis in the era of
combination antiretroviral therapy
Charles Chan*; Leslie Lee-Pack; R. Palmer; C.K.N. Chan, Canada
22183 Risk factors for pneumocystis carinii pneumonia in the U.S.
Jeffrey Duchin*; P. Simon; T.M. Hooton; S.G. Hopkins; B.H. Sohlberg;
S.E. Buskin; J.L. Jones, USA
22184 Detection of pneumocystis carinii-DNA by nested-PCR in
bronchoalveolar lavage (BAL): advantages and questions
Elena Visconti*; Maria Zolfo; S. Marinaci; D. Zinzi; P. Mencarini;

E. Tamburrini, Italy

22185 Gender-specific risk of pneumocystis carinii pneumonia as an initial AIDS
indicator disease among adults in California
Farzaneh Tabnak*; A. Gilson; R. Sun; J.M. Colford, USA
22186 Withdrawal of pneumocystis carinii pneumonia (PCP) prophylaxis after
HAART in patients with AIDS
Elisa Garcia Vazquez*;J. Marrero Frances; R. Garcia Delgado; C. Mainez;
M. Gorgolas; M.L. Fernandez Guerero, Spain
22187 Risk factors associated with breakthrough PCP
Scott McCallister*; Jennifer Barnes, US
22188 Validation of a multisystem organ failure (MSOF) score for
pneumocystis carinii pneumonia (PCP) and acute respiratory failure
(ARF)
David Forrest*; 0. Djurdjev; C. Zala;J. Russel;J.S.G. Montaner, Canada,
Argentina
22189 Randomized, double-blind, placebo-controlled trial of erythromycin
versus ciprofloxacin for the treatment of chancroid
Stephen Moses*; I.M. Malonza; M. Tyndall; J. Perriens; F.A. Plummer; A.R.
Ronald;J.0. Ndinya-Achola, Canada, Kenya, Canada, Switzerland, Canada
22190 Declines in syphilis prevalence in pregnancy and in STD syndromes
among clinic attenders at five primary health care centres in Nairobi,
Kenya, 1993 to 1997
Stephen Moses*; E.N. Ngugi; DJ. Jackson; A. Gikuni; L. Gathingu;
R.C. Brunham; F.A. Plummer, Canada, Kenya
22191 Prevalence and clinical expression of herpes simplex virus infections
among women enrolled in the Women's Interagency HIV Study (WIHS),
United States
Ruth Greenblatt*; R. Ashley; N. Ameli; M. Augenbraun; M. Young;
D. Burns; M. Cohen, USA
22192 Impact of HAART on clinical evolution of genital warts in HIV-positive
patients
Orlando Giovanna*; Rosamarina Signori; M.M. Fasolo; M. Schiavini;
A. Casella; A. Gargnel, Italy
22193 Women personal collection of specimens as an alternate strategy in
fighting STD without speculum
Juan Carlos Flichman*; K. Amodio Siemaszko; AG. Di Noto; JM. Mendez
Ribas, Argentina
22194 Gonorrhea and Chlamydia: Lack of co-infection in homosexual men
Scott McCallister*;Joseph W. Henry, US
NOTES

JUNE

CONFERENCE WORKBOOK

85